Failure of myelin basic protein to prevent or suppress experimental allergic encephalomyelitis in guinea pigs

Abstract

The encephalitogenic myelin basic protein (BP) was reported to be effective in preventing and suppressing the development of experimental allergic encephalomyelitis (EAE) when animals were treated before or after encephalitogenic challenge, respectively. In this report we show that pretreatment with 15 daily doses of 2.5 or 0.15 mg homologous BP (in IFA… (More)
DOI: 10.1007/BF00964325

Topics

  • Presentations referencing similar topics